PEDIATRICS Vol. 100 No. 4 October 1997, pp. 640-646
Received Mar 30, 1995; accepted Feb 18, 1997.
, and
From the * § Department of Obstetrics and Gynecology, Royal
Victoria Hospital, Quebec, Montreal, Canada;
Division of Clinical
Epidemiology, Montreal General Hospital, Montreal, Quebec, Canada; and
Departments of * § Pediatrics and
Epidemiology and
Biostatistics, McGill University, Quebec, Montreal, Canada.
Objective. To quantify the factors associated with growth of very small premature infants during initial hospitalization.
Population. Study patients were 109 infants who were appropriate for gestational age, weighed <1000 g at birth, and were fed intravenous hyperalimentation then calcium-supplemented 81-kcal preterm formula according to a protocol.
Analysis. Multiple regression analysis was performed for periods of 0 to 56, 0 to 14, and 15 to 56 days of age. Growth was determined as change in weight during the period. Variables assessed in the initial model were caloric intake, protein intake, respiratory support duration, patent ductus arteriosus, dexamethasone use, infection, birth weight ratio (weight divided by expected intrauterine weight for gestation), gestational age, sex, calendar time from study start, maternal betamethasone administration, and necrotizing enterocolitis. For the 0 to 14-day period, maximum oxygen requirement for respiratory distress syndrome replaced respiratory support duration, and 5-minute Apgar score was added, whereas dexamethasone and necrotizing enterocolitis were deleted.
Results. Mean change in weight was 785 g for 0 to 56 days,
16 g for 0 to 14 days, and 770 g for 15 to 56 days. Mean
weight was 94% (13 SD) of mean intrauterine at birth, 73% (10 SD) at 14 days, and 73% (12 SD) at 56 days. Regression models explained 85%,
43%, and 80%, respectively, of variation in growth.
Of the initial variables assessed, the following were the independent prognostic determinants of growth. There was a positive association with caloric intake at 0 to 56 days and 15 to 56 days, and with protein intake at 0 to 14 days. Negative associations were found for birth weight ratio and gestational age at 0 to 56 and 0 to 14 days. Respiratory support duration was negatively associated at 15 to 56 days, and dexamethasone was negatively associated at 0 to 56 and 15 to 56 days. Formulas to predict growth were established from the final regression models.
Conclusion. The growth failure in appropriate-for-gestational-age, <1000-g birth weight infants can be related in part to dexamethasone use and respiratory support duration. Increasing caloric intake and early protein intake improves growth. However, for the majority of these patients, early losses are not corrected completely by 56 days using currently recommended intakes.
Key words: growth, infant, premature, multivariate analysis.
This article has been cited by other articles:
![]() |
J. Koch, G. Hensley, L. Roy, S. Brown, C. Ramaciotti, and C. R. Rosenfeld Prevalence of Spontaneous Closure of the Ductus Arteriosus in Neonates at a Birth Weight of 1000 Grams or Less Pediatrics, April 1, 2006; 117(4): 1113 - 1121. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. N. Finer, R. J. Powers, C.-h. S. Ou, D. Durand, D. Wirtschafter, J. B. Gould, and for the California Perinatal Quality Care Collabor Prospective Evaluation of Postnatal Steroid Administration: A 1-Year Experience From the California Perinatal Quality Care Collaborative Pediatrics, March 1, 2006; 117(3): 704 - 713. [Abstract] [Full Text] [PDF] |
||||
![]() |
R W I Cooke Are there critical periods for brain growth in children born preterm? Arch. Dis. Child. Fetal Neonatal Ed., January 1, 2006; 91(1): F17 - F20. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. L. Patel, J. L. Engstrom, P. P. Meier, and R. E. Kimura Accuracy of Methods for Calculating Postnatal Growth Velocity for Extremely Low Birth Weight Infants Pediatrics, December 1, 2005; 116(6): 1466 - 1473. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. G.S. Philip and R. Usher Historical Perspectives: Neonatology: The Long View NeoReviews, January 1, 2005; 6(1): e3 - e11. [Full Text] [PDF] |
||||
![]() |
J. K. Jackson, D. J. Biondo, J. M. Jones, P. J. Moor, S. D. Simon, R. T. Hall, and H. W. Kilbride Can an Alternative Umbilical Arterial Catheter Solution and Flush Regimen Decrease Iatrogenic Hemolysis While Enhancing Nutrition? A Double-Blind, Randomized, Clinical Trial Comparing an Isotonic Amino Acid With a Hypotonic Salt Infusion Pediatrics, August 1, 2004; 114(2): 377 - 383. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. R. Neal Jr., G. Weidemann, M. Kabbaj, and D. M. Vazquez Effect of neonatal dexamethasone exposure on growth and neurological development in the adult rat Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2004; 287(2): R375 - R385. [Abstract] [Full Text] [PDF] |
||||
![]() |
R W I Cooke and L Foulder-Hughes Growth impairment in the very preterm and cognitive and motor performance at 7 years Arch. Dis. Child., June 1, 2003; 88(6): 482 - 487. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. E. Olsen, D. K. Richardson, C. H. Schmid, L. M. Ausman, and J. T. Dwyer Intersite Differences in Weight Growth Velocity of Extremely Premature Infants Pediatrics, December 1, 2002; 110(6): 1125 - 1132. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. B. Flagel, D. M. Vazquez, S. J. Watson Jr., and C. R. Neal Jr. Effects of tapering neonatal dexamethasone on rat growth, neurodevelopment, and stress response Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2002; 282(1): R55 - R63. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. K. Steward and K. F. Pridham Stability of Respiratory Quotient and Growth Outcomes of Very Low Birth Weight Infants Biol Res Nurs, January 1, 2001; 2(3): 198 - 205. [Abstract] [PDF] |
||||
![]() |
J. K Jackson and D. P Derleth Effects of various arterial infusion solutions on red blood cells in the newborn Arch. Dis. Child. Fetal Neonatal Ed., September 1, 2000; 83(2): 130F - 134. [Abstract] [Full Text] |
||||
![]() |
M. A. Berry, H. Conrod, and R. H. Usher Growth of Very Premature Infants Fed Intravenous Hyperalimentation and Calcium-supplemented Formula Pediatrics, October 1, 1997; 100(4): 647 - 653. [Abstract] [Full Text] [PDF] |
||||